Polyunsaturated fatty acids for treatment of dementia and pre-dementia-related conditions

Polyunsaturated fatty acids for treatment of dementia and pre-dementia-related conditions

  • CN 103,211,807 A
  • Filed: 07/07/2006
  • Published: 07/24/2013
  • Est. Priority Date: 07/08/2005
  • Status: Active Application
First Claim
Patent Images

1. the purposes of compositions in the preparation medicine that comprises docosahexenoic acid (DHA), wherein said compositions comprises that it is about 1.36% or lower that the amount of eicosapentaenoic acid (EPA) accounts for total fatty acids percentage ratio, and medicine is formulated as and is used for Orally administered medicine to suffer from relevant cognitive decline of age or moderate (mild) cognitive impairment with treatment be the people of the preceding dementia of feature.

View all claims
    ×
    ×

    Thank you for your feedback

    ×
    ×